Prevalence and risk factors of Strongyloides stercoralis in haemodialysis in Cochabamba, Bolivia: a cross-sectional study.
Chronic kidney failure
Disseminated strongyloidiasis
Hyperinfection syndrome
Renal dialysis
Strongyloides stercoralis
Journal
BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793
Informations de publication
Date de publication:
07 02 2023
07 02 2023
Historique:
received:
06
07
2022
accepted:
31
01
2023
entrez:
8
2
2023
pubmed:
9
2
2023
medline:
10
2
2023
Statut:
epublish
Résumé
Strongyloidiasis is an infectious disease that can be fatal in immunocompromised patients. Patients with end-stage renal failure who are on dialysis have a considerably weakened immune system, and organ transplantation is a major risk factor for severe strongyloidiasis. Knowledge of the local epidemiology in tropical and subtropical areas is an essential prerequisite for designing an appropriate strategy to prevent this potentially lethal complication. In this study, we aimed to estimate the prevalence and associated risk factors of S. stercoralis infection in patients on dialysis in Cochabamba, Bolivia. A cross-sectional study was carried out among patients undergoing haemodialysis in Cochabamba (elevation 2,500 m, temperate climate), collecting information on socio-demographic, lifestyle, and clinical variables, and using one coproparasitological technique (the modified Baermann technique) and one serological (ELISA) test for S.stercoralis diagnosis. In total, 149 patients participated in the study (mean age = 51.4 years, 48.3% male). End-stage renal disease was predominantly (59%) of hypertensive and/or diabetic origin. The positive serological prevalence was 18.8% (95% CI: 13.3%-25.9%). Based on the sensitivity and specificity of the ELISA test, the estimate of the actual prevalence was 15.1% (95% CI: 9.4%-20.7%). Stool samples of 105 patients (70.5%) showed a coproparasitological prevalence of 1.9% (95% CI: 0.52%-6.68%). No potential risk factors were significantly associated with S. stercoralis infection. We found a high seroprevalence of S. stercoralis in Bolivian patients undergoing haemodialysis in Cochabamba. We recommend presumptive antiparasitic treatment at regular intervals to avoid the potentially fatal complications of severe strongyloidiasis.
Sections du résumé
BACKGROUND
Strongyloidiasis is an infectious disease that can be fatal in immunocompromised patients. Patients with end-stage renal failure who are on dialysis have a considerably weakened immune system, and organ transplantation is a major risk factor for severe strongyloidiasis. Knowledge of the local epidemiology in tropical and subtropical areas is an essential prerequisite for designing an appropriate strategy to prevent this potentially lethal complication. In this study, we aimed to estimate the prevalence and associated risk factors of S. stercoralis infection in patients on dialysis in Cochabamba, Bolivia.
METHODS
A cross-sectional study was carried out among patients undergoing haemodialysis in Cochabamba (elevation 2,500 m, temperate climate), collecting information on socio-demographic, lifestyle, and clinical variables, and using one coproparasitological technique (the modified Baermann technique) and one serological (ELISA) test for S.stercoralis diagnosis.
RESULTS
In total, 149 patients participated in the study (mean age = 51.4 years, 48.3% male). End-stage renal disease was predominantly (59%) of hypertensive and/or diabetic origin. The positive serological prevalence was 18.8% (95% CI: 13.3%-25.9%). Based on the sensitivity and specificity of the ELISA test, the estimate of the actual prevalence was 15.1% (95% CI: 9.4%-20.7%). Stool samples of 105 patients (70.5%) showed a coproparasitological prevalence of 1.9% (95% CI: 0.52%-6.68%). No potential risk factors were significantly associated with S. stercoralis infection.
CONCLUSIONS
We found a high seroprevalence of S. stercoralis in Bolivian patients undergoing haemodialysis in Cochabamba. We recommend presumptive antiparasitic treatment at regular intervals to avoid the potentially fatal complications of severe strongyloidiasis.
Identifiants
pubmed: 36750775
doi: 10.1186/s12882-023-03074-9
pii: 10.1186/s12882-023-03074-9
pmc: PMC9903486
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
27Informations de copyright
© 2023. The Author(s).
Références
J Am Soc Nephrol. 2006 Jul;17(7):2034-47
pubmed: 16738019
Clin Microbiol Infect. 2015 Jun;21(6):543-52
pubmed: 25887711
IDCases. 2021;25:e01192
pubmed: 34150517
Kidney Int. 2000 Oct;58(4):1758-64
pubmed: 11012910
BMC Infect Dis. 2013 Feb 08;13:78
pubmed: 23394259
Chest. 2001 Dec;120(6):1883-7
pubmed: 11742917
Trans R Soc Trop Med Hyg. 2006 Nov;100(11):1056-62
pubmed: 16551471
Nephrol Dial Transplant. 2008 Mar;23(3):800-7
pubmed: 18065804
Am J Trop Med Hyg. 2006 Jan;74(1):97-102
pubmed: 16407351
Pathogens. 2020 Jun 13;9(6):
pubmed: 32545787
Curr Opin Infect Dis. 2012 Aug;25(4):458-63
pubmed: 22691685
Infect Dis Clin North Am. 2019 Mar;33(1):135-151
pubmed: 30712758
Parasitology. 2012 Sep;139(11):1513-20
pubmed: 22813776
PLoS Negl Trop Dis. 2013 Jul 11;7(7):e2288
pubmed: 23875033
Infection. 2015 Dec;43(6):691-8
pubmed: 26008854
PLoS Negl Trop Dis. 2013 May 09;7(5):e2214
pubmed: 23675546
Adv Parasitol. 1996;38:251-309
pubmed: 8701797
Clin Microbiol Rev. 2004 Jan;17(1):208-17
pubmed: 14726461
PLoS Negl Trop Dis. 2019 Jan 17;13(1):e0007028
pubmed: 30653489
Kidney Int. 1999 Mar;55(3):1081-90
pubmed: 10027947
PLoS Negl Trop Dis. 2014 Jan 09;8(1):e2640
pubmed: 24427320
Parasitology. 2017 Mar;144(3):263-273
pubmed: 27181117
Clin Infect Dis. 2009 Nov 1;49(9):1411-23
pubmed: 19807271
Emerg Infect Dis. 2011 May;17(5):931-2
pubmed: 21529417
Eur J Clin Microbiol Infect Dis. 2006 Jan;25(1):14-8
pubmed: 16418832
PLoS One. 2015 Apr 24;10(4):e0124547
pubmed: 25910221
Clin J Am Soc Nephrol. 2008 Sep;3(5):1526-33
pubmed: 18701615
Trans R Soc Trop Med Hyg. 2009 Oct;103(10):967-72
pubmed: 19328508
Intern Med J. 2018 Jul;48(7):872-875
pubmed: 29984512